Table 1.
Pathology results by fecal immunochemical test value.
| 10–14.9 μg/g (50–74 ng/mL) (N/%) |
15–19.9 μg/g (75–99 ng/mL) (N/%) |
20–39.9 μg/g (100–199 ng/mL) (N/%) |
40–99.9 μg/g (200–499 ng/mL) (N/%) |
≥100 μg/g (≥500 ng/mL) (N/%) |
Total (N/%) |
|
|---|---|---|---|---|---|---|
| CRC | 40 (0.6) | 21 (0.7) | 44 (1.1) | 102 (3.2) | 242 (8.4) | 449 (2.3) |
| HRA | 836 (12.6) | 464 (15.8) | 801 (19.8) | 802 (25.4) | 1109 (38.4) | 4012 (20.4) |
| MLRA | 401 (6.0) | 188 (6.4) | 263 (6.5) | 189 (6.0) | 132 (4.6) | 1173 (6.0) |
| LRA | 1857 (28.0) | 813 (27.7) | 1112 (27.5) | 773 (24.5) | 474 (16.4) | 5029 (25.6) |
| No neoplasia | 3507 (52.8) | 1444 (49.3) | 1824 (45.1) | 1292 (40.9) | 930 (32.2) | 8997 (45.8) |
| Total | 6641 | 2930 | 4044 | 3158 | 2887 | 19660 |
CRC, colorectal cancer; HRA, high-risk adenoma; LRA, low-risk adenoma; MLRA, multiple low-risk adenomas.